Skip to content

Post Doctoral Training Fellow - Chemical Proteomics Data Analyst

06/09/2018, 23:55

Sutton and London
Cancer Therapeutics
Translational Cancer Discovery
Full time
Fixed Term
2 years
35
£30,410 - £42,211
The Institute of Cancer Research, London, is one of the world’s most influential cancer research institutes, with an outstanding record of achievement dating back more than 100 years. We provided the first convincing evidence that DNA damage is the basic cause of cancer, laying the foundation for the now universally accepted idea that cancer is a genetic disease. Today, The Institute of Cancer Research (ICR) leads the world at isolating cancer-related genes and discovering new targeted drugs for personalised cancer treatment.

Under the leadership of our Chief Executive, Professor Paul Workman FRS, the ICR is ranked as the UK’s leading academic research centre. Together with our partner The Royal Marsden, we are rated in the top four cancer centres globally.

The ICR is committed to attracting, developing and retaining the best minds in the world to join us in our mission – to make the discoveries that defeat cancer.

The Cancer Research UK Cancer Therapeutics Unit, within the Division of Cancer Therapeutics, is a multidisciplinary 'bench to bedside' centre, comprising around 160 staff dedicated to the discovery and development of novel therapeutics for the treatment of cancer. The Cancer Therapeutics Unit’s exciting goal is to discover high quality drug candidates for validated biological targets and to progress these candidates to clinical trial. All the scientific disciplines are in place to make this possible. Our biologists work alongside world-class chemists and drug metabolism specialists focusing on new molecular targets emerging from human genome and ground breaking cell biology research. This is an exciting and fast moving area of cancer research, and offers the opportunity to work within a multi-disciplinary environment using state-of-the-art techniques and equipment.


This Unit is now under the leadership of Professor Rajesh Chopra who has previously held senior leadership positions at AstraZeneca and Celgene and academic positions in the UK in haematological oncology and stem cell transplantation.


The Functional Proteomics unit is located at the Chester Beatty Labs, in Chelsea. This unit is led by Dr Jyoti Choudhary, also the Head of Mass Spectrometry Unit at the ICR.


The unit has leading edge Proteomics and Metabolomics technologies, including several Orbitrap and Time of Flight mass spectrometers.


This vibrant team are comprised of experimental and computational scientists that develop quantitative mass spectrometry to characterise diverse protein attributes. The team have expertise in large scale proteomics for basic and clinical applications. The unit is located within the Division of Cancer Biology.


Starting salary in the region of £30,410 to £42,211 pa inclusive (based on previous experience). Appointment will be for 24 months in the first instance. Further information can be found below in the attached full job description. 


We consider all applications on merit and have a strong commitment to enhancing the diversity of our staff.
Additional Documentation for Candidates

This Program is closed to applications.